Xing-Qi Dong
Overview
Explore the profile of Xing-Qi Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li N, Li R, Zheng H, He W, Duan R, Li X, et al.
BMC Infect Dis
. 2025 Feb;
25(1):264.
PMID: 39994545
Background: Achieving complete immune reconstitution (CIR) in people living with human immunodeficiency virus (PLWH) following antiretroviral therapy (ART) is essential for preventing acquired immunodeficiency syndrome (AIDS) progression and improving survival....
2.
Li N, Zheng H, Li W, He X, Zhang M, Li X, et al.
Immun Ageing
. 2025 Jan;
22(1):3.
PMID: 39780181
Background: Older people living with HIV-1 (PLWH) experience a dual burden from the combined effects of aging and HIV-1 infection, resulting in significant immune dysfunction. Despite receiving HAART, immune reconstitution...
3.
Cheng P, He B, Wu Z, Liu J, Wang J, Yang C, et al.
AIDS Res Hum Retroviruses
. 2024 Oct;
41(1):1-10.
PMID: 39419590
Heterosexuals have become the most prevalent group of HIV-1 in Kunming, Yunnan Province. Utilizing the principle of genetic similarity between their gene sequences, we built a molecular transmission network by...
4.
Li N, Zheng H, He W, He X, Li R, Cui W, et al.
AIDS
. 2024 Apr;
38(6):803-812.
PMID: 38578958
Objectives: There is conflicting data regarding the response of older people with HIV (PWH) to antiretroviral therapy (ART). The objective of this study was to evaluate the long-term immunological and...
5.
Shen F, Liang C, Yang C, Lu Y, Li A, Duan Y, et al.
Virol Sin
. 2023 Nov;
39(1):173-176.
PMID: 38000528
No abstract available.
6.
Cheng P, He B, Liu J, Wang J, Yang C, Ma S, et al.
AIDS Res Hum Retroviruses
. 2023 Sep;
40(5):353-362.
PMID: 37658836
HIV-1 is the most prevalent epidemic subtype among heterosexual (HET) and intravenous drug users (IDUs) in Kunming, Yunnan. Using the pol region of gene sequences derived from molecular epidemiological surveys,...
7.
Shen F, Yang C, Lu Y, Zhang M, Tian R, Dong X, et al.
J Med Virol
. 2023 Jan;
95(2):e28516.
PMID: 36680413
In China, most SARS-CoV-2-infected individuals had been vaccinated with inactivated vaccines. However, little is known about their immune resistances to the previous variants of concerns (VOCs) and the current Omicron...
8.
Pang W, Lu Y, Zhao Y, Shen F, Fan C, Wang Q, et al.
Cell Res
. 2022 Nov;
32(12):1068-1085.
PMID: 36357786
The emerging SARS-CoV-2 variants, commonly with many mutations in S1 subunit of spike (S) protein are weakening the efficacy of the current vaccines and antibody therapeutics. This calls for the...
9.
Feng X, Yu D, Zhang M, Li X, Zou Q, Ma W, et al.
Virol Sin
. 2022 Sep;
37(6):804-812.
PMID: 36167254
The continuously arising of SARS-CoV-2 variants has been posting a great threat to public health safety globally, from B.1.17 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta) to B.1.1.529 (Omicron). The...
10.
Huang X, Tian R, Ma M, Luo R, Yang L, Peng G, et al.
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337136
Latent reservoir persistence remains a major obstacle for curing human immunodeficiency virus type 1 (HIV-1) infection. Thus, strategies for the elimination of latent HIV-1 are urgently needed. As a bromodomain...